首页> 外文期刊>Pancreas >Screening of R122H and N29I mutations in the PRSS1 gene and N34S mutation in the SPINK1 gene in Mexican pediatric patients with acute and recurrent pancreatitis
【24h】

Screening of R122H and N29I mutations in the PRSS1 gene and N34S mutation in the SPINK1 gene in Mexican pediatric patients with acute and recurrent pancreatitis

机译:墨西哥小儿急性和复发性胰腺炎患者PRSS1基因的R122H和N29I突变以及SPINK1基因的N34S突变的筛选

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: The study's objective was to assess the association between the PRSS1 R122H and N29I and the SPINK1 N34S mutations and acute pancreatitis (AP) and recurrent pancreatitis in Mexican pediatric patients. Methods: The N34S and R122H mutations were detected using polymerase chain reaction-restriction fragment length polymorphism, and the N29I mutation was detected using allele-specific polymerase chain reaction in 92 pancreatitis patients (58 AP and 34 recurrent pancreatitis patients) and 144 controls. Results: We found 1 mutated allele in 4 (4.3%) of 92 pancreatitis patients and none in the controls. All 4 patients bearing mutations had AP, with a frequency of 6.8% (4/58). Three (5.2%) of 58 patients were heterozygous for the N34S mutation, and 1 (1.7%) of 58 patients was heterozygous for the N29I mutation. The comparison between the AP and control groups revealed both a significant number of patients carrying any mutations in the screened genes (P = 0.008) and bearing the N34S mutation (P = 0.023). Moreover, we found that the N34S G allele increased the risk of developing AP (odds ratio, 10.3; confidence interval, 1.1-248.8). Conclusions: Patients bearing the N34S G allele exhibited a 10-fold increased risk of developing AP compared with controls, suggesting that the SPINK1 N34S mutation represents an etiologic risk factor for AP in our Mexican pediatric patients.
机译:目的:本研究的目的是评估墨西哥小儿患者的PRSS1 R122H和N29I与SPINK1 N34S突变与急性胰腺炎(AP)和复发性胰腺炎之间的关系。方法:对92例胰腺炎患者(58例AP和34例复发性胰腺炎患者)和144例对照者采用聚合酶链反应-限制性片段长度多态性检测N34S和R122H突变,等位基因特异性聚合酶链反应检测N29I突变。结果:我们在92例胰腺炎患者中的4例(4.3%)中发现了1个突变的等位基因,而在对照组中均没有。所有有突变的4例患者均患有AP,频率为6.8%(4/58)。 58名患者中有3名(5.2%)是N34S突变的杂合子,58名患者中有1名(1.7%)是N29I突变的杂合子。 AP组与对照组之间的比较表明,有大量患者携带所筛选基因的任何突变(P = 0.008)并带有N34S突变(P = 0.023)。此外,我们发现N34S G等位基因会增加患AP的风险(比值比为10.3;置信区间为1.1-248.8)。结论:带有N34S G等位基因的患者与对照组相比,患AP的风险增加了10倍,这表明SPINK1 N34S突变代表了我们墨西哥儿童患者AP的病因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号